img

Global Thrombin (Human) Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Thrombin (Human) Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

The global Thrombin (Human) market size was US$ 565 million in 2022 and is forecast to a readjusted size of US$ 704.7 million by 2034 with a CAGR of 3.2% during the forecast period 2024-2034.
The United States market for Thrombin (Human) is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Thrombin (Human) is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Thrombin (Human) is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034..
The global key manufacturers of Thrombin (Human) include Baxter, AMRESCO Inc, BD Biosciences, Life Technologies Corporation, PromoCell GmbH, Sigma-Aldrich Corporation, Vitrolife AB, CSL and Bayer, etc. In 2022, the global top five players hold a share approximately % in sales volume, and in term of revenue of Thrombin (Human), the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Thrombin (Human) by regions (Countries), company, by type and by type. from 2018 to 2024 and forecast to 2034.
The global Thrombin (Human) market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Thrombin (Human) market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Baxter
AMRESCO Inc
BD Biosciences
Life Technologies Corporation
PromoCell GmbH
Sigma-Aldrich Corporation
Vitrolife AB
CSL
Bayer
Grifols
Octapharma
Shanghai RAAS
Hualan Biological
By Type
500IU/Vial
1000IU/Vial
2500IU/Vial
By Application
Biotechnology
Medicine
Microbiology
Others
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Thrombin (Human) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Thrombin (Human) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Thrombin (Human) sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Thrombin (Human) Definition
1.2 Market by Type
1.2.1 Global Thrombin (Human) Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 500IU/Vial
1.2.3 1000IU/Vial
1.2.4 2500IU/Vial
1.3 Market Segment by Application
1.3.1 Global Thrombin (Human) Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Biotechnology
1.3.3 Medicine
1.3.4 Microbiology
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Thrombin (Human) Sales
2.1 Global Thrombin (Human) Revenue Estimates and Forecasts 2018-2034
2.2 Global Thrombin (Human) Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Thrombin (Human) Revenue by Region
2.3.1 Global Thrombin (Human) Revenue by Region (2018-2024)
2.3.2 Global Thrombin (Human) Revenue by Region (2024-2034)
2.4 Global Thrombin (Human) Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Thrombin (Human) Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Thrombin (Human) Sales Quantity by Region
2.6.1 Global Thrombin (Human) Sales Quantity by Region (2018-2024)
2.6.2 Global Thrombin (Human) Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Thrombin (Human) Sales Quantity by Manufacturers
3.1.1 Global Thrombin (Human) Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Thrombin (Human) Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Thrombin (Human) Sales in 2022
3.2 Global Thrombin (Human) Revenue by Manufacturers
3.2.1 Global Thrombin (Human) Revenue by Manufacturers (2018-2024)
3.2.2 Global Thrombin (Human) Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Thrombin (Human) Revenue in 2022
3.3 Global Thrombin (Human) Sales Price by Manufacturers
3.4 Global Key Players of Thrombin (Human), Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Thrombin (Human) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Thrombin (Human), Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Thrombin (Human), Product Offered and Application
3.8 Global Key Manufacturers of Thrombin (Human), Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Thrombin (Human) Sales Quantity by Type
4.1.1 Global Thrombin (Human) Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Thrombin (Human) Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Thrombin (Human) Sales Quantity Market Share by Type (2018-2034)
4.2 Global Thrombin (Human) Revenue by Type
4.2.1 Global Thrombin (Human) Historical Revenue by Type (2018-2024)
4.2.2 Global Thrombin (Human) Forecasted Revenue by Type (2024-2034)
4.2.3 Global Thrombin (Human) Revenue Market Share by Type (2018-2034)
4.3 Global Thrombin (Human) Price by Type
4.3.1 Global Thrombin (Human) Price by Type (2018-2024)
4.3.2 Global Thrombin (Human) Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Thrombin (Human) Sales Quantity by Application
5.1.1 Global Thrombin (Human) Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Thrombin (Human) Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Thrombin (Human) Sales Quantity Market Share by Application (2018-2034)
5.2 Global Thrombin (Human) Revenue by Application
5.2.1 Global Thrombin (Human) Historical Revenue by Application (2018-2024)
5.2.2 Global Thrombin (Human) Forecasted Revenue by Application (2024-2034)
5.2.3 Global Thrombin (Human) Revenue Market Share by Application (2018-2034)
5.3 Global Thrombin (Human) Price by Application
5.3.1 Global Thrombin (Human) Price by Application (2018-2024)
5.3.2 Global Thrombin (Human) Price Forecast by Application (2024-2034)
6 North America
6.1 North America Thrombin (Human) Sales by Company
6.1.1 North America Thrombin (Human) Revenue by Company (2018-2024)
6.1.2 North America Thrombin (Human) Sales Quantity by Company (2018-2024)
6.2 North America Thrombin (Human) Market Size by Type
6.2.1 North America Thrombin (Human) Sales Quantity by Type (2018-2034)
6.2.2 North America Thrombin (Human) Revenue by Type (2018-2034)
6.3 North America Thrombin (Human) Market Size by Application
6.3.1 North America Thrombin (Human) Sales Quantity by Application (2018-2034)
6.3.2 North America Thrombin (Human) Revenue by Application (2018-2034)
6.4 North America Thrombin (Human) Market Size by Country
6.4.1 North America Thrombin (Human) Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Thrombin (Human) Revenue by Country (2018-2034)
6.4.3 North America Thrombin (Human) Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Thrombin (Human) Sales by Company
7.1.1 Europe Thrombin (Human) Sales Quantity by Company (2018-2024)
7.1.2 Europe Thrombin (Human) Revenue by Company (2018-2024)
7.2 Europe Thrombin (Human) Market Size by Type
7.2.1 Europe Thrombin (Human) Sales Quantity by Type (2018-2034)
7.2.2 Europe Thrombin (Human) Revenue by Type (2018-2034)
7.3 Europe Thrombin (Human) Market Size by Application
7.3.1 Europe Thrombin (Human) Sales Quantity by Application (2018-2034)
7.3.2 Europe Thrombin (Human) Revenue by Application (2018-2034)
7.4 Europe Thrombin (Human) Market Size by Country
7.4.1 Europe Thrombin (Human) Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Thrombin (Human) Revenue by Country (2018-2034)
7.4.3 Europe Thrombin (Human) Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Thrombin (Human) Sales by Company
8.1.1 China Thrombin (Human) Sales Quantity by Company (2018-2024)
8.1.2 China Thrombin (Human) Revenue by Company (2018-2024)
8.2 China Thrombin (Human) Market Size by Type
8.2.1 China Thrombin (Human) Sales Quantity by Type (2018-2034)
8.2.2 China Thrombin (Human) Revenue by Type (2018-2034)
8.3 China Thrombin (Human) Market Size by Application
8.3.1 China Thrombin (Human) Sales Quantity by Application (2018-2034)
8.3.2 China Thrombin (Human) Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Thrombin (Human) Sales by Company
9.1.1 APAC Thrombin (Human) Sales Quantity by Company (2018-2024)
9.1.2 APAC Thrombin (Human) Revenue by Company (2018-2024)
9.2 APAC Thrombin (Human) Market Size by Type
9.2.1 APAC Thrombin (Human) Sales Quantity by Type (2018-2034)
9.2.2 APAC Thrombin (Human) Revenue by Type (2018-2034)
9.3 APAC Thrombin (Human) Market Size by Application
9.3.1 APAC Thrombin (Human) Sales Quantity by Application (2018-2034)
9.3.2 APAC Thrombin (Human) Revenue by Application (2018-2034)
9.4 APAC Thrombin (Human) Market Size by Region
9.4.1 APAC Thrombin (Human) Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Thrombin (Human) Revenue by Region (2018-2034)
9.4.3 APAC Thrombin (Human) Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Thrombin (Human) Sales by Company
10.1.1 Middle East, Africa and Latin America Thrombin (Human) Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Thrombin (Human) Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Thrombin (Human) Market Size by Type
10.2.1 Middle East, Africa and Latin America Thrombin (Human) Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Thrombin (Human) Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Thrombin (Human) Market Size by Application
10.3.1 Middle East, Africa and Latin America Thrombin (Human) Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Thrombin (Human) Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Thrombin (Human) Market Size by Country
10.4.1 Middle East, Africa and Latin America Thrombin (Human) Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Thrombin (Human) Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Thrombin (Human) Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Baxter
11.1.1 Baxter Company Information
11.1.2 Baxter Overview
11.1.3 Baxter Thrombin (Human) Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Baxter Thrombin (Human) Products and Services
11.1.5 Baxter Thrombin (Human) SWOT Analysis
11.1.6 Baxter Recent Developments
11.2 AMRESCO Inc
11.2.1 AMRESCO Inc Company Information
11.2.2 AMRESCO Inc Overview
11.2.3 AMRESCO Inc Thrombin (Human) Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 AMRESCO Inc Thrombin (Human) Products and Services
11.2.5 AMRESCO Inc Thrombin (Human) SWOT Analysis
11.2.6 AMRESCO Inc Recent Developments
11.3 BD Biosciences
11.3.1 BD Biosciences Company Information
11.3.2 BD Biosciences Overview
11.3.3 BD Biosciences Thrombin (Human) Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 BD Biosciences Thrombin (Human) Products and Services
11.3.5 BD Biosciences Thrombin (Human) SWOT Analysis
11.3.6 BD Biosciences Recent Developments
11.4 Life Technologies Corporation
11.4.1 Life Technologies Corporation Company Information
11.4.2 Life Technologies Corporation Overview
11.4.3 Life Technologies Corporation Thrombin (Human) Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 Life Technologies Corporation Thrombin (Human) Products and Services
11.4.5 Life Technologies Corporation Thrombin (Human) SWOT Analysis
11.4.6 Life Technologies Corporation Recent Developments
11.5 PromoCell GmbH
11.5.1 PromoCell GmbH Company Information
11.5.2 PromoCell GmbH Overview
11.5.3 PromoCell GmbH Thrombin (Human) Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 PromoCell GmbH Thrombin (Human) Products and Services
11.5.5 PromoCell GmbH Thrombin (Human) SWOT Analysis
11.5.6 PromoCell GmbH Recent Developments
11.6 Sigma-Aldrich Corporation
11.6.1 Sigma-Aldrich Corporation Company Information
11.6.2 Sigma-Aldrich Corporation Overview
11.6.3 Sigma-Aldrich Corporation Thrombin (Human) Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 Sigma-Aldrich Corporation Thrombin (Human) Products and Services
11.6.5 Sigma-Aldrich Corporation Thrombin (Human) SWOT Analysis
11.6.6 Sigma-Aldrich Corporation Recent Developments
11.7 Vitrolife AB
11.7.1 Vitrolife AB Company Information
11.7.2 Vitrolife AB Overview
11.7.3 Vitrolife AB Thrombin (Human) Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 Vitrolife AB Thrombin (Human) Products and Services
11.7.5 Vitrolife AB Thrombin (Human) SWOT Analysis
11.7.6 Vitrolife AB Recent Developments
11.8 CSL
11.8.1 CSL Company Information
11.8.2 CSL Overview
11.8.3 CSL Thrombin (Human) Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.8.4 CSL Thrombin (Human) Products and Services
11.8.5 CSL Thrombin (Human) SWOT Analysis
11.8.6 CSL Recent Developments
11.9 Bayer
11.9.1 Bayer Company Information
11.9.2 Bayer Overview
11.9.3 Bayer Thrombin (Human) Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.9.4 Bayer Thrombin (Human) Products and Services
11.9.5 Bayer Thrombin (Human) SWOT Analysis
11.9.6 Bayer Recent Developments
11.10 Grifols
11.10.1 Grifols Company Information
11.10.2 Grifols Overview
11.10.3 Grifols Thrombin (Human) Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.10.4 Grifols Thrombin (Human) Products and Services
11.10.5 Grifols Thrombin (Human) SWOT Analysis
11.10.6 Grifols Recent Developments
11.11 Octapharma
11.11.1 Octapharma Company Information
11.11.2 Octapharma Overview
11.11.3 Octapharma Thrombin (Human) Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.11.4 Octapharma Thrombin (Human) Products and Services
11.11.5 Octapharma Recent Developments
11.12 Shanghai RAAS
11.12.1 Shanghai RAAS Company Information
11.12.2 Shanghai RAAS Overview
11.12.3 Shanghai RAAS Thrombin (Human) Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.12.4 Shanghai RAAS Thrombin (Human) Products and Services
11.12.5 Shanghai RAAS Recent Developments
11.13 Hualan Biological
11.13.1 Hualan Biological Company Information
11.13.2 Hualan Biological Overview
11.13.3 Hualan Biological Thrombin (Human) Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.13.4 Hualan Biological Thrombin (Human) Products and Services
11.13.5 Hualan Biological Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Thrombin (Human) Value Chain Analysis
12.2 Thrombin (Human) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Thrombin (Human) Production Mode & Process
12.4 Thrombin (Human) Sales and Marketing
12.4.1 Thrombin (Human) Sales Channels
12.4.2 Thrombin (Human) Distributors
12.5 Thrombin (Human) Customers
13 Market Dynamics
13.1 Thrombin (Human) Industry Trends
13.2 Thrombin (Human) Market Drivers
13.3 Thrombin (Human) Market Challenges
13.4 Thrombin (Human) Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Thrombin (Human) Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of 500IU/Vial
Table 3. Major Manufacturers of 1000IU/Vial
Table 4. Major Manufacturers of 2500IU/Vial
Table 5. Global Thrombin (Human) Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Thrombin (Human) Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Thrombin (Human) Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global Thrombin (Human) Revenue Market Share by Region (2018-2024)
Table 9. Global Thrombin (Human) Revenue by Region (2024-2034) & (US$ Million)
Table 10. Global Thrombin (Human) Revenue Market Share by Region (2024-2034)
Table 11. Global Thrombin (Human) Sales Quantity by Region: 2018 VS 2022 VS 2034 (K Units)
Table 12. Global Thrombin (Human) Sales by Region (2018-2024) & (K Units)
Table 13. Global Thrombin (Human) Sales Market Share by Region (2018-2024)
Table 14. Global Thrombin (Human) Sales by Region (2024-2034) & (K Units)
Table 15. Global Thrombin (Human) Sales Market Share by Region (2024-2034)
Table 16. Global Thrombin (Human) Sales Quantity by Manufacturers (2018-2024) & (K Units)
Table 17. Global Thrombin (Human) Sales Quantity Share by Manufacturers (2018-2024)
Table 18. Global Thrombin (Human) Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 19. Global Thrombin (Human) Revenue Share by Manufacturers (2018-2024)
Table 20. Global Thrombin (Human) Price by Manufacturers 2018-2024 (USD/Unit)
Table 21. Global Key Players of Thrombin (Human), Industry Ranking, 2021 VS 2022
Table 22. Global Thrombin (Human) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Thrombin (Human) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Thrombin (Human) as of 2022)
Table 24. Global Key Manufacturers of Thrombin (Human), Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Thrombin (Human), Product Offered and Application
Table 26. Global Key Manufacturers of Thrombin (Human), Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Thrombin (Human) Sales Quantity by Type (2018-2024) & (K Units)
Table 29. Global Thrombin (Human) Sales Quantity by Type (2024-2034) & (K Units)
Table 30. Global Thrombin (Human) Sales Quantity Share by Type (2018-2024)
Table 31. Global Thrombin (Human) Sales Quantity Share by Type (2024-2034)
Table 32. Global Thrombin (Human) Revenue by Type (2018-2024) & (US$ Million)
Table 33. Global Thrombin (Human) Revenue by Type (2024-2034) & (US$ Million)
Table 34. Global Thrombin (Human) Revenue Share by Type (2018-2024)
Table 35. Global Thrombin (Human) Revenue Share by Type (2024-2034)
Table 36. Thrombin (Human) Price by Type (2018-2024) & (USD/Unit)
Table 37. Global Thrombin (Human) Price Forecast by Type (2024-2034) & (USD/Unit)
Table 38. Global Thrombin (Human) Sales Quantity by Application (2018-2024) & (K Units)
Table 39. Global Thrombin (Human) Sales Quantity by Application (2024-2034) & (K Units)
Table 40. Global Thrombin (Human) Sales Quantity Share by Application (2018-2024)
Table 41. Global Thrombin (Human) Sales Quantity Share by Application (2024-2034)
Table 42. Global Thrombin (Human) Revenue by Application (2018-2024) & (US$ Million)
Table 43. Global Thrombin (Human) Revenue by Application (2024-2034) & (US$ Million)
Table 44. Global Thrombin (Human) Revenue Share by Application (2018-2024)
Table 45. Global Thrombin (Human) Revenue Share by Application (2024-2034)
Table 46. Thrombin (Human) Price by Application (2018-2024) & (USD/Unit)
Table 47. Global Thrombin (Human) Price Forecast by Application (2024-2034) & (USD/Unit)
Table 48. North America Thrombin (Human) Revenue by Company (2018-2024) & (US$ Million)
Table 49. North America Thrombin (Human) Sales Quantity by Company (2018-2024) & (K Units)
Table 50. North America Thrombin (Human) Sales Quantity by Type (2018-2024) & (K Units)
Table 51. North America Thrombin (Human) Sales Quantity by Type (2024-2034) & (K Units)
Table 52. North America Thrombin (Human) Revenue by Type (2018-2024) & (US$ Million)
Table 53. North America Thrombin (Human) Revenue by Type (2024-2034) & (US$ Million)
Table 54. North America Thrombin (Human) Sales Quantity by Application (2018-2024) & (K Units)
Table 55. North America Thrombin (Human) Sales Quantity by Application (2024-2034) & (K Units)
Table 56. North America Thrombin (Human) Revenue by Application (2018-2024) & (US$ Million)
Table 57. North America Thrombin (Human) Revenue by Application (2024-2034) & (US$ Million)
Table 58. North America Thrombin (Human) Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 59. North America Thrombin (Human) Revenue by Country (2018-2024) & (US$ Million)
Table 60. North America Thrombin (Human) Revenue by Country (2024-2034) & (US$ Million)
Table 61. North America Thrombin (Human) Sales Quantity by Country (2018-2024) & (K Units)
Table 62. North America Thrombin (Human) Sales Quantity by Country (2024-2034) & (K Units)
Table 63. Europe Thrombin (Human) Sales Quantity by Company (2018-2024) & (K Units)
Table 64. Europe Thrombin (Human) Revenue by Company (2018-2024) & (US$ Million)
Table 65. Europe Thrombin (Human) Sales Quantity by Type (2018-2024) & (K Units)
Table 66. Europe Thrombin (Human) Sales Quantity by Type (2024-2034) & (K Units)
Table 67. Europe Thrombin (Human) Revenue by Type (2018-2024) & (US$ Million)
Table 68. Europe Thrombin (Human) Revenue by Type (2024-2034) & (US$ Million)
Table 69. Europe Thrombin (Human) Sales Quantity by Application (2018-2024) & (K Units)
Table 70. Europe Thrombin (Human) Sales Quantity by Application (2024-2034) & (K Units)
Table 71. Europe Thrombin (Human) Revenue by Application (2018-2024) & (US$ Million)
Table 72. Europe Thrombin (Human) Revenue by Application (2024-2034) & (US$ Million)
Table 73. Europe Thrombin (Human) Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 74. Europe Thrombin (Human) Revenue by Country (2018-2024) & (US$ Million)
Table 75. Europe Thrombin (Human) Revenue by Country (2024-2034) & (US$ Million)
Table 76. Europe Thrombin (Human) Sales Quantity by Country (2018-2024) & (K Units)
Table 77. Europe Thrombin (Human) Sales Quantity by Country (2024-2034) & (K Units)
Table 78. China Thrombin (Human) Sales Quantity by Company (2018-2024) & (K Units)
Table 79. China Thrombin (Human) Revenue by Company (2018-2024) & (US$ Million)
Table 80. China Thrombin (Human) Sales Quantity by Type (2018-2024) & (K Units)
Table 81. China Thrombin (Human) Sales Quantity by Type (2024-2034) & (K Units)
Table 82. China Thrombin (Human) Revenue by Type (2018-2024) & (US$ Million)
Table 83. China Thrombin (Human) Revenue by Type (2024-2034) & (US$ Million)
Table 84. China Thrombin (Human) Sales Quantity by Application (2018-2024) & (K Units)
Table 85. China Thrombin (Human) Sales Quantity by Application (2024-2034) & (K Units)
Table 86. China Thrombin (Human) Revenue by Application (2018-2024) & (US$ Million)
Table 87. China Thrombin (Human) Revenue by Application (2024-2034) & (US$ Million)
Table 88. APAC Thrombin (Human) Sales Quantity by Company (2018-2024) & (K Units)
Table 89. APAC Thrombin (Human) Revenue by Company (2018-2024) & (US$ Million)
Table 90. APAC Thrombin (Human) Sales Quantity by Type (2018-2024) & (K Units)
Table 91. APAC Thrombin (Human) Sales Quantity by Type (2024-2034) & (K Units)
Table 92. APAC Thrombin (Human) Revenue by Type (2018-2024) & (US$ Million)
Table 93. APAC Thrombin (Human) Revenue by Type (2024-2034) & (US$ Million)
Table 94. APAC Thrombin (Human) Sales Quantity by Application (2018-2024) & (K Units)
Table 95. APAC Thrombin (Human) Sales Quantity by Application (2024-2034) & (K Units)
Table 96. APAC Thrombin (Human) Revenue by Application (2018-2024) & (US$ Million)
Table 97. APAC Thrombin (Human) Revenue by Application (2024-2034) & (US$ Million)
Table 98. APAC Thrombin (Human) Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 99. APAC Thrombin (Human) Revenue by Region (2018-2024) & (US$ Million)
Table 100. APAC Thrombin (Human) Revenue by Region (2024-2034) & (US$ Million)
Table 101. APAC Thrombin (Human) Sales Quantity by Region (2018-2024) & (K Units)
Table 102. APAC Thrombin (Human) Sales Quantity by Region (2024-2034) & (K Units)
Table 103. Middle East, Africa and Latin America Thrombin (Human) Sales Quantity by Company (2018-2024) & (K Units)
Table 104. Middle East, Africa and Latin America Thrombin (Human) Revenue by Company (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Thrombin (Human) Sales Quantity by Type (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Thrombin (Human) Sales Quantity by Type (2024-2034) & (K Units)
Table 107. Middle East, Africa and Latin America Thrombin (Human) Revenue by Type (2018-2024) & (US$ Million)
Table 108. Middle East, Africa and Latin America Thrombin (Human) Revenue by Type (2024-2034) & (US$ Million)
Table 109. Middle East, Africa and Latin America Thrombin (Human) Sales Quantity by Application (2018-2024) & (K Units)
Table 110. Middle East, Africa and Latin America Thrombin (Human) Sales Quantity by Application (2024-2034) & (K Units)
Table 111. Middle East, Africa and Latin America Thrombin (Human) Revenue by Application (2018-2024) & (US$ Million)
Table 112. Middle East, Africa and Latin America Thrombin (Human) Revenue by Application (2024-2034) & (US$ Million)
Table 113. Middle East, Africa and Latin America Thrombin (Human) Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 114. Middle East, Africa and Latin America Thrombin (Human) Revenue by Country (2018-2024) & (US$ Million)
Table 115. Middle East, Africa and Latin America Thrombin (Human) Revenue by Country (2024-2034) & (US$ Million)
Table 116. Middle East, Africa and Latin America Thrombin (Human) Sales Quantity by Country (2018-2024) & (K Units)
Table 117. Middle East, Africa and Latin America Thrombin (Human) Sales Quantity by Country (2024-2034) & (K Units)
Table 118. Baxter Company Information
Table 119. Baxter Description and Overview
Table 120. Baxter Thrombin (Human) Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 121. Baxter Thrombin (Human) Product and Services
Table 122. Baxter Thrombin (Human) SWOT Analysis
Table 123. Baxter Recent Developments
Table 124. AMRESCO Inc Company Information
Table 125. AMRESCO Inc Description and Overview
Table 126. AMRESCO Inc Thrombin (Human) Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 127. AMRESCO Inc Thrombin (Human) Product and Services
Table 128. AMRESCO Inc Thrombin (Human) SWOT Analysis
Table 129. AMRESCO Inc Recent Developments
Table 130. BD Biosciences Company Information
Table 131. BD Biosciences Description and Overview
Table 132. BD Biosciences Thrombin (Human) Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 133. BD Biosciences Thrombin (Human) Product and Services
Table 134. BD Biosciences Thrombin (Human) SWOT Analysis
Table 135. BD Biosciences Recent Developments
Table 136. Life Technologies Corporation Company Information
Table 137. Life Technologies Corporation Description and Overview
Table 138. Life Technologies Corporation Thrombin (Human) Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 139. Life Technologies Corporation Thrombin (Human) Product and Services
Table 140. Life Technologies Corporation Thrombin (Human) SWOT Analysis
Table 141. Life Technologies Corporation Recent Developments
Table 142. PromoCell GmbH Company Information
Table 143. PromoCell GmbH Description and Overview
Table 144. PromoCell GmbH Thrombin (Human) Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 145. PromoCell GmbH Thrombin (Human) Product and Services
Table 146. PromoCell GmbH Thrombin (Human) SWOT Analysis
Table 147. PromoCell GmbH Recent Developments
Table 148. Sigma-Aldrich Corporation Company Information
Table 149. Sigma-Aldrich Corporation Description and Overview
Table 150. Sigma-Aldrich Corporation Thrombin (Human) Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 151. Sigma-Aldrich Corporation Thrombin (Human) Product and Services
Table 152. Sigma-Aldrich Corporation Thrombin (Human) SWOT Analysis
Table 153. Sigma-Aldrich Corporation Recent Developments
Table 154. Vitrolife AB Company Information
Table 155. Vitrolife AB Description and Overview
Table 156. Vitrolife AB Thrombin (Human) Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 157. Vitrolife AB Thrombin (Human) Product and Services
Table 158. Vitrolife AB Thrombin (Human) SWOT Analysis
Table 159. Vitrolife AB Recent Developments
Table 160. CSL Company Information
Table 161. CSL Description and Overview
Table 162. CSL Thrombin (Human) Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 163. CSL Thrombin (Human) Product and Services
Table 164. CSL Thrombin (Human) SWOT Analysis
Table 165. CSL Recent Developments
Table 166. Bayer Company Information
Table 167. Bayer Description and Overview
Table 168. Bayer Thrombin (Human) Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 169. Bayer Thrombin (Human) Product and Services
Table 170. Bayer Thrombin (Human) SWOT Analysis
Table 171. Bayer Recent Developments
Table 172. Grifols Company Information
Table 173. Grifols Description and Overview
Table 174. Grifols Thrombin (Human) Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 175. Grifols Thrombin (Human) Product and Services
Table 176. Grifols Thrombin (Human) SWOT Analysis
Table 177. Grifols Recent Developments
Table 178. Octapharma Company Information
Table 179. Octapharma Description and Overview
Table 180. Octapharma Thrombin (Human) Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 181. Octapharma Thrombin (Human) Product and Services
Table 182. Octapharma Recent Developments
Table 183. Shanghai RAAS Company Information
Table 184. Shanghai RAAS Description and Overview
Table 185. Shanghai RAAS Thrombin (Human) Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 186. Shanghai RAAS Thrombin (Human) Product and Services
Table 187. Shanghai RAAS Recent Developments
Table 188. Hualan Biological Company Information
Table 189. Hualan Biological Description and Overview
Table 190. Hualan Biological Thrombin (Human) Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 191. Hualan Biological Thrombin (Human) Product and Services
Table 192. Hualan Biological Recent Developments
Table 193. Key Raw Materials Lists
Table 194. Raw Materials Key Suppliers Lists
Table 195. Thrombin (Human) Distributors List
Table 196. Thrombin (Human) Customers List
Table 197. Thrombin (Human) Market Trends
Table 198. Thrombin (Human) Market Drivers
Table 199. Thrombin (Human) Market Challenges
Table 200. Thrombin (Human) Market Restraints
Table 201. Research Programs/Design for This Report
Table 202. Key Data Information from Secondary Sources
Table 203. Key Data Information from Primary Sources
List of Figures
Figure 1. Thrombin (Human) Product Picture
Figure 2. Global Thrombin (Human) Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Thrombin (Human) Market Share by Type in 2022 & 2034
Figure 4. 500IU/Vial Product Picture
Figure 5. 1000IU/Vial Product Picture
Figure 6. 2500IU/Vial Product Picture
Figure 7. Global Thrombin (Human) Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 8. Global Thrombin (Human) Market Share by Application in 2022 & 2034
Figure 9. Biotechnology
Figure 10. Medicine
Figure 11. Microbiology
Figure 12. Others
Figure 13. Thrombin (Human) Report Years Considered
Figure 14. Global Thrombin (Human) Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 15. Global Thrombin (Human) Revenue 2018-2034 (US$ Million)
Figure 16. Global Thrombin (Human) Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 17. Global Thrombin (Human) Sales Quantity 2018-2034 (K Units)
Figure 18. Global Thrombin (Human) Sales Quantity Market Share by Region (2018-2024)
Figure 19. Global Thrombin (Human) Sales Quantity Market Share by Region (2024-2034)
Figure 20. North America Thrombin (Human) Sales Quantity YoY (2018-2034) & (K Units)
Figure 21. North America Thrombin (Human) Revenue YoY (2018-2034) & (US$ Million)
Figure 22. Europe Thrombin (Human) Sales Quantity YoY (2018-2034) & (K Units)
Figure 23. Europe Thrombin (Human) Revenue YoY (2018-2034) & (US$ Million)
Figure 24. China Thrombin (Human) Sales Quantity YoY (2018-2034) & (K Units)
Figure 25. China Thrombin (Human) Revenue YoY (2018-2034) & (US$ Million)
Figure 26. APAC Thrombin (Human) Sales Quantity YoY (2018-2034) & (K Units)
Figure 27. APAC Thrombin (Human) Revenue YoY (2018-2034) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Thrombin (Human) Sales Quantity YoY (2018-2034) & (K Units)
Figure 29. Middle East, Africa and Latin America Thrombin (Human) Revenue YoY (2018-2034) & (US$ Million)
Figure 30. The Top 10 and Top 5 Players Market Share by Thrombin (Human) Sales Quantity in 2022
Figure 31. The Top 10 and Top 5 Players Market Share by Thrombin (Human) Revenue in 2022
Figure 32. Thrombin (Human) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global Thrombin (Human) Sales Quantity Market Share by Type (2018-2034)
Figure 34. Global Thrombin (Human) Revenue Market Share by Type (2018-2034)
Figure 35. Global Thrombin (Human) Sales Quantity Market Share by Application (2018-2034)
Figure 36. Global Thrombin (Human) Revenue Market Share by Application (2018-2034)
Figure 37. North America Thrombin (Human) Revenue Market Share by Company in 2022
Figure 38. North America Thrombin (Human) Sales Quantity Market Share by Company in 2022
Figure 39. North America Thrombin (Human) Sales Quantity Market Share by Type (2018-2034)
Figure 40. North America Thrombin (Human) Revenue Market Share by Type (2018-2034)
Figure 41. North America Thrombin (Human) Sales Quantity Market Share by Application (2018-2034)
Figure 42. North America Thrombin (Human) Revenue Market Share by Application (2018-2034)
Figure 43. North America Thrombin (Human) Revenue Share by Country (2018-2034)
Figure 44. North America Thrombin (Human) Sales Quantity Share by Country (2018-2034)
Figure 45. U.S. Thrombin (Human) Revenue (2018-2034) & (US$ Million)
Figure 46. Canada Thrombin (Human) Revenue (2018-2034) & (US$ Million)
Figure 47. Europe Thrombin (Human) Sales Quantity Market Share by Company in 2022
Figure 48. Europe Thrombin (Human) Revenue Market Share by Company in 2022
Figure 49. Europe Thrombin (Human) Sales Quantity Market Share by Type (2018-2034)
Figure 50. Europe Thrombin (Human) Revenue Market Share by Type (2018-2034)
Figure 51. Europe Thrombin (Human) Sales Quantity Market Share by Application (2018-2034)
Figure 52. Europe Thrombin (Human) Revenue Market Share by Application (2018-2034)
Figure 53. Europe Thrombin (Human) Revenue Share by Country (2018-2034)
Figure 54. Europe Thrombin (Human) Sales Quantity Share by Country (2018-2034)
Figure 55. Germany Thrombin (Human) Revenue (2018-2034) & (US$ Million)
Figure 56. France Thrombin (Human) Revenue (2018-2034) & (US$ Million)
Figure 57. U.K. Thrombin (Human) Revenue (2018-2034) & (US$ Million)
Figure 58. Italy Thrombin (Human) Revenue (2018-2034) & (US$ Million)
Figure 59. Russia Thrombin (Human) Revenue (2018-2034) & (US$ Million)
Figure 60. China Thrombin (Human) Sales Quantity Market Share by Company in 2022
Figure 61. China Thrombin (Human) Revenue Market Share by Company in 2022
Figure 62. China Thrombin (Human) Sales Quantity Market Share by Type (2018-2034)
Figure 63. China Thrombin (Human) Revenue Market Share by Type (2018-2034)
Figure 64. China Thrombin (Human) Sales Quantity Market Share by Application (2018-2034)
Figure 65. China Thrombin (Human) Revenue Market Share by Application (2018-2034)
Figure 66. APAC Thrombin (Human) Sales Quantity Market Share by Company in 2022
Figure 67. APAC Thrombin (Human) Revenue Market Share by Company in 2022
Figure 68. APAC Thrombin (Human) Sales Quantity Market Share by Type (2018-2034)
Figure 69. APAC Thrombin (Human) Revenue Market Share by Type (2018-2034)
Figure 70. APAC Thrombin (Human) Sales Quantity Market Share by Application (2018-2034)
Figure 71. APAC Thrombin (Human) Revenue Market Share by Application (2018-2034)
Figure 72. APAC Thrombin (Human) Revenue Share by Region (2018-2034)
Figure 73. APAC Thrombin (Human) Sales Quantity Share by Region (2018-2034)
Figure 74. Japan Thrombin (Human) Revenue (2018-2034) & (US$ Million)
Figure 75. South Korea Thrombin (Human) Revenue (2018-2034) & (US$ Million)
Figure 76. China Taiwan Thrombin (Human) Revenue (2018-2034) & (US$ Million)
Figure 77. Southeast Asia Thrombin (Human) Revenue (2018-2034) & (US$ Million)
Figure 78. India Thrombin (Human) Revenue (2018-2034) & (US$ Million)
Figure 79. Middle East, Africa and Latin America Thrombin (Human) Sales Quantity Market Share by Company in 2022
Figure 80. Middle East, Africa and Latin America Thrombin (Human) Revenue Market Share by Company in 2022
Figure 81. Middle East, Africa and Latin America Thrombin (Human) Sales Quantity Market Share by Type (2018-2034)
Figure 82. Middle East, Africa and Latin America Thrombin (Human) Revenue Market Share by Type (2018-2034)
Figure 83. Middle East, Africa and Latin America Thrombin (Human) Sales Quantity Market Share by Application (2018-2034)
Figure 84. Middle East, Africa and Latin America Thrombin (Human) Revenue Market Share by Application (2018-2034)
Figure 85. Middle East, Africa and Latin America Thrombin (Human) Sales Quantity Share by Country (2018-2034)
Figure 86. Middle East, Africa and Latin America Thrombin (Human) Revenue Share by Country (2018-2034)
Figure 87. Brazil Thrombin (Human) Revenue (2018-2034) & (US$ Million)
Figure 88. Mexico Thrombin (Human) Revenue (2018-2034) & (US$ Million)
Figure 89. Turkey Thrombin (Human) Revenue (2018-2034) & (US$ Million)
Figure 90. Israel Thrombin (Human) Revenue (2018-2034) & (US$ Million)
Figure 91. GCC Countries Thrombin (Human) Revenue (2018-2034) & (US$ Million)
Figure 92. Thrombin (Human) Value Chain
Figure 93. Thrombin (Human) Production Process
Figure 94. Channels of Distribution (Direct Vs Distribution)
Figure 95. Distributors Profiles
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed